Associate Director - External Innovation S&E Diabetes & Obesity
Scorpion Therapeutics, Boston, Massachusetts, us, 02298
Role Summary
Associate Director, External Innovation Diabetes & Obesity at Lilly. This role will help develop and implement Lilly’s External Innovation and Search & Evaluation strategy and priorities to secure pipeline impact across Diabetes & Obesity. Working closely with Cardiometabolic Research, the role supports processes related to identification and evaluation of new opportunities, prepares in-depth documents delineating opportunities from scientific and business perspectives, and manages partner interactions as projects progress from initial sanctioning through deal closure. Responsibilities
Identify and map new innovative opportunities with bold understanding of disease biology. Rigorously assess programs from biotech, small and large pharma for potential in-licensing/partnering opportunities assigned for review by leadership or identified proactively. Manage all stages of partner interactions and evaluations, including initial contact, securing internal interest, meeting execution, coordinating internal debriefs, and supporting CMR Search & Evaluation leadership as needed. Ensure prompt evaluation by functional experts (Biology, Chemistry, CMC, ADME, TOX, PK, legal etc.) for opportunity evaluation and pre-diligence, and provide partners with essential feedback/guidance. Identify gaps and key issues and appropriate expertise to enable resolution. Collaborate with internal scientific teams to identify, design, and implement the scientific experiments necessary to validate external opportunities. Support consolidation of scientific feedback leading to internal recommendations and provision of partner responses. Maintain awareness of external competitive landscapes for key target areas and assets by actively monitoring external preclinical- and clinical-stage assets within therapeutic areas. Engage in scientific conferences as directed by CMR S&E leadership to scout for new assets and technologies in line with R&D priorities. Provide regular updates at EI deals review sessions. Qualifications
Required: PhD in Life Sciences related field, with track record in pre-clinical research and deep understanding of R&D processes and new modalities in the Diabetes & Obesity area. Required: Minimum of 1-5 years of experience in the pharmaceutical industry. Required: Strong scientific pedigree as evidenced by publications and presentations. Required: Minimum of 1-2 years of experience in external research collaborations and S&E. Preferred: Proven ability to work independently as well as in highly integrated cross-functional teams. Preferred: Strong interpersonal and communication skills and the ability to represent Lilly in a highly professional manner. Preferred: Track record of participation in scientific conferences in the cardiometabolic/WHS area and partnering conferences. Preferred: Demonstrated track record in managing complex partnerships. Additional Requirements
25% travel anticipated Remote location tbd
#J-18808-Ljbffr
Associate Director, External Innovation Diabetes & Obesity at Lilly. This role will help develop and implement Lilly’s External Innovation and Search & Evaluation strategy and priorities to secure pipeline impact across Diabetes & Obesity. Working closely with Cardiometabolic Research, the role supports processes related to identification and evaluation of new opportunities, prepares in-depth documents delineating opportunities from scientific and business perspectives, and manages partner interactions as projects progress from initial sanctioning through deal closure. Responsibilities
Identify and map new innovative opportunities with bold understanding of disease biology. Rigorously assess programs from biotech, small and large pharma for potential in-licensing/partnering opportunities assigned for review by leadership or identified proactively. Manage all stages of partner interactions and evaluations, including initial contact, securing internal interest, meeting execution, coordinating internal debriefs, and supporting CMR Search & Evaluation leadership as needed. Ensure prompt evaluation by functional experts (Biology, Chemistry, CMC, ADME, TOX, PK, legal etc.) for opportunity evaluation and pre-diligence, and provide partners with essential feedback/guidance. Identify gaps and key issues and appropriate expertise to enable resolution. Collaborate with internal scientific teams to identify, design, and implement the scientific experiments necessary to validate external opportunities. Support consolidation of scientific feedback leading to internal recommendations and provision of partner responses. Maintain awareness of external competitive landscapes for key target areas and assets by actively monitoring external preclinical- and clinical-stage assets within therapeutic areas. Engage in scientific conferences as directed by CMR S&E leadership to scout for new assets and technologies in line with R&D priorities. Provide regular updates at EI deals review sessions. Qualifications
Required: PhD in Life Sciences related field, with track record in pre-clinical research and deep understanding of R&D processes and new modalities in the Diabetes & Obesity area. Required: Minimum of 1-5 years of experience in the pharmaceutical industry. Required: Strong scientific pedigree as evidenced by publications and presentations. Required: Minimum of 1-2 years of experience in external research collaborations and S&E. Preferred: Proven ability to work independently as well as in highly integrated cross-functional teams. Preferred: Strong interpersonal and communication skills and the ability to represent Lilly in a highly professional manner. Preferred: Track record of participation in scientific conferences in the cardiometabolic/WHS area and partnering conferences. Preferred: Demonstrated track record in managing complex partnerships. Additional Requirements
25% travel anticipated Remote location tbd
#J-18808-Ljbffr